European Committee on Antimicrobial Susceptibility Testing
|
|
- Angelina Dennis
- 6 years ago
- Views:
Transcription
1 European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from This document should be cited as "The European Committee on Antimicrobial Susceptibility Testing. Routine and extended internal quality control as recommended by EUCAST. Version 5.0, General Page Notes 1 Changes Routine quality control Page Escherichia coli ATCC 59 Escherichia coli ATCC Pseudomonas aeruginosa ATCC Staphylococcus aureus ATCC 91 7 Enterococcus faecalis ATCC 91 8 Streptococcus pneumoniae ATCC Haemophilus influenzae NCTC Haemophilus influenzae ATCC Campylobacter jejuni ATCC Extended quality control for detection of resistance mechanisms with disk diffusion Page Klebsiella pneumoniae ATCC Staphylococcus aureus NCTC Enterococcus faecalis ATCC Haemophilus influenzae ATCC
2 EUCAST QC Tables v. 5.0, valid from Notes 1. In EUCAST quality control (QC) tables, both ranges and targets are listed. Repeat testing of EUCAST quality control strains should yield individual and zone diameter values randomly distributed within the recommended ranges. If the number of tests is 10, the mode should be the target value and the mean zone diameter should be close to the target value.. For access to ISO standard documents, see EUCAST quality control strains for routine QC are used to monitor test performance. Control tests should be set up and checked daily, at least for antibiotic agents which are part of routine panels. For analysis of the QC test results, see EUCAST Disk Diffusion Manual, section E. coli ATCC 518 (TEM-1 β-lactamase-producing strain) is recommended to check the inhibitor component of penicillin inhibitor-combination disks for antimicrobial susceptibility testing of Enterobacteriaceae and should be part of the routine QC. E. coli ATCC 59 is used to check the active component. 5. EUCAST quality control strains for extended QC are complementary to the EUCAST routine quality control strains. These strains are recommended for detection of specific resistance mechanisms (ESBL, MRSA, VRE, HLGR and PBP mutations) and are used to check that routine susceptibility testing will result in the correct S, I and R categorisation. Extended QC should be performed with any change in the susceptibility testing system (with each new batch of disks or medium) and/or monthly. 1
3 EUCAST QC Tables v. 5.0, valid from Changes from previous version Version General ATCC 59 ATCC 518 ATCC NCTC 8468 ATCC Changes Cells containing a change or an addition from EUCAST Routine QC tables v. 4.0 or Extended QC tables v 1.0 are marked yellow. EUCAST QC strains for routine and extended quality control presented in one table. New recommendations for quality control of penicillin inhibitor-combination disks. Included in routine quality control of penicillin inhibitor-combination disks. QC ranges added: Amoxicillin-clavulanic acid, ampicillin-sulbactam and piperacillin-tazobactam (). Ticarcillin-clavulanic acid ( and zone diameter). Alternative test with S. aureus ATCC 91 added for oxacillin 1 µg. H. influenzae NCTC 8468 exhibits unusual growth characteristics and will be excluded from 016. QC ranges added: Amoxicillin range. Zone diameter ranges for amoxicillin-clavulanic acid, ampicillin, benzylpenicillin, cefepime, cefixime, cefotaxime, cefpodoxime, cefuroxime, chloramphenicol, doripenem, ertapenem, erythromycin, imipenem, meropenem, minocycline, nalidixic acid, rifampicin, telithromycin, tetracycline and trimethoprimsulfamethoxazole.
4 Routine QC EUCAST QC Tables v. 5.0, valid from Escherichia coli ATCC 59 (NCTC 141, CIP 76.4, DSM 110, CCUG 1760, CECT 44) Disk diffusion methodology: Mueller-Hinton agar, McFarland 0.5, air, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the back of the plate against a dark background illuminated with reflected light. Target 1 Range (µg) Target 1 Range Amikacin Amoxicillin Amoxicillin-clavulanic acid 4, Ampicillin Ampicillin-sulbactam 5, Aztreonam Cefadroxil Cefalexin Cefepime Cefixime Cefotaxime Cefoxitin Cefpodoxime Ceftaroline Ceftazidime Ceftibuten Ceftobiprole IP IP IP Ceftriaxone Cefuroxime Chloramphenicol Ciprofloxacin Colistin Doripenem Ertapenem Fosfomycin Gentamicin Imipenem Levofloxacin Mecillinam Meropenem Moxifloxacin Nalidixic acid Netilmicin Nitrofurantoin Norfloxacin Ofloxacin Pefloxacin Piperacillin Piperacillin-tazobactam 5, Ticarcillin Ticarcillin-clavulanic acid 4, Tigecycline Tobramycin Trimethoprim Trimethoprim-sulfamethoxazole
5 Routine QC EUCAST QC Tables v. 5.0, valid from Escherichia coli ATCC 59 (NCTC 141, CIP 76.4, DSM 110, CCUG 1760, CECT 44) From International Standards Organisation, ISO : 006 (with updates as in the latest CLSI M100 document), except ranges in bold/italics established by EUCAST. From Clinical and Laboratory Standards Institute, M100-S5, 015, except ranges in bold/italics established by EUCAST. All ranges have been validated by EUCAST. 4 For testing, the concentration of clavulanic acid is fixed at mg/l. 5 E. coli ATCC 518 (TEM-1 β-lactamase-producing strain) is used to check the inhibitor component. 6 Ignore growth that may appear as a thin inner zone on some batches of Mueller-Hinton agar. 7 For testing, the concentration of sulbactam is fixed at 4 mg/l. 8 For fosfomycin determination, the medium must be supplemented with glucose-6-phosphate to a final concentration of 5 mg/l. 9 For testing, the concentration of tazobactam is fixed at 4 mg/l. 10 For tigecycline broth microdilution determination, the medium must be prepared fresh on the day of use. 11 Trimethoprim:sulfamethoxazole in the ratio 1:19. values are expressed as the trimethoprim concentration. IP = In Preparation 4
6 Routine QC EUCAST QC Tables v. 5.0, valid from Escherichia coli ATCC 518 (NCTC 11954, CIP 10181, DSM 59, CCUG 0600, CECT 94) TEM-1 β-lactamase-producing strain (non-esbl) used to check the inhibitor component of penicillin inhibitpr combination disks. Disk diffusion methodology: Mueller-Hinton agar, McFarland 0.5, air, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the back of the plate against a dark background illuminated with reflected light. Target 1 Range (µg) Target 1 Range Amoxicillin-clavulanic acid Ampicillin-sulbactam Piperacillin-tazobactam Ticarcillin-clavulanic acid From Clinical and Laboratory Standards Institute, M100-S5, 015, except ranges in bold/italics established by EUCAST. All ranges have been validated by EUCAST. For testing, the concentration of clavulanic acid is fixed at mg/l. 4 Ignore growth that may appear as a thin inner zone on some batches of Mueller-Hinton agar. 5 For testing, the concentration of sulbactam is fixed at 4 mg/l. 6 For testing, the concentration of tazobactam is fixed at 4 mg/l. 5
7 Routine QC EUCAST QC Tables v. 5.0, valid from Pseudomonas aeruginosa ATCC 785 (NCTC 190, CIP , DSM 1117, CCUG 17619, CECT 108) Disk diffusion methodology: Mueller-Hinton agar, McFarland 0.5, air, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the back of the plate against a dark background illuminated with reflected light. Target 1 Range (µg) Target 1 Range Amikacin Aztreonam Cefepime Ceftazidime Ciprofloxacin Colistin Doripenem Fosfomycin Gentamicin Imipenem Levofloxacin Meropenem Netilmicin Piperacillin Piperacillin-tazobactam Ticarcillin Ticarcillin-clavulanic acid Tobramycin From International Standards Organisation, ISO : 006 (with updates as in the latest CLSI M100 document). From Clinical and Laboratory Standards Institute, M100-S5, 015, except ranges in bold/italics established by EUCAST. All ranges have been validated by EUCAST. 4 For fosfomycin determination, the medium must be supplemented with glucose-6-phosphate to a final concentration of 5 mg/l. 5 For testing, the concentration of tazobactam is fixed at 4 mg/l. 6 For testing, the concentration of clavulanic acid is fixed at mg/l. 6
8 Routine QC EUCAST QC Tables v. 5.0, valid from Staphylococcus aureus ATCC 91 (NCTC 197, CIP 1049, DSM 569, CCUG 15915, CECT 794) β-lactamase-producing strain (weak) Disk diffusion methodology: Mueller-Hinton agar, McFarland 0.5, air, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the back of the plate against a dark background illuminated with reflected light. Target 1 Range (µg) Target 1 Range Amikacin Ampicillin Azithromycin Benzylpenicillin unit Cefoxitin Ceftaroline Ceftobiprole IP IP IP Chloramphenicol Ciprofloxacin Clarithromycin Clindamycin Daptomycin Doxycycline Erythromycin Fosfomycin Fusidic acid Gentamicin Levofloxacin Linezolid Minocycline Moxifloxacin Mupirocin Netilmicin Nitrofurantoin Norfloxacin Ofloxacin Quinupristin-dalfopristin Rifampicin Teicoplanin Telavancin Tetracycline Tigecycline Tobramycin Trimethoprim Trimethoprim-sulfamethoxazole Vancomycin From International Standards Organisation, ISO : 006 (with updates as in the latest CLSI M100 document). Established and validated by EUCAST. 4 From Clinical and Laboratory Standards Institute, M100-S5, 015, and validated by EUCAST. 5 For daptomycin determination, the medium must be supplemented with Ca + to a final concentration of 50 mg/l. 6 For fosfomycin determination, the medium must be supplemented with glucose-6-phosphate to a final concentration of 5 mg/l. 7 For telavancin determination, the medium must be supplemented with polysorbate-80 to a final concentration of 0.00%. 8 For tigecycline broth microdilution determination, the medium must be prepared fresh on the day of use. 9 Trimethoprim:sulfamethoxazole in the ratio 1:19. values are expressed as the trimethoprim concentration. IP = In Preparation 7
9 Routine QC EUCAST QC Tables v. 5.0, valid from Enterococcus faecalis ATCC 91 (NCTC 1697, CIP 1014, DSM 570, CCUG 9997, CECT 795) Disk diffusion methodology: Mueller-Hinton agar, McFarland 0.5, air, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the back of the plate against a dark background illuminated with reflected light. Target 1 Range (µg) Target 1 Range Ampicillin Ciprofloxacin Gentamicin Imipenem Levofloxacin Linezolid Nitrofurantoin Norfloxacin Quinupristin-dalfopristin Teicoplanin Tigecycline Trimethoprim Trimethoprim-sulfamethoxazole Vancomycin From International Standards Organisation, ISO : 006 (with updates as in the latest CLSI M100 document). Established and validated by EUCAST. 4 Screening disk for high-level aminoglycoside-resistance in enterococci. 5 For tigecycline broth microdilution determination, the medium must be prepared fresh on the day of use. 6 From Clinical and Laboratory Standards Institute, M100-S5, Trimethoprim:sulfamethoxazole in the ratio 1:19. values are expressed as the trimethoprim concentration. 8
10 Routine QC EUCAST QC Tables v. 5.0, valid from Streptococcus pneumoniae ATCC 49619* (NCTC 1977, CIP 10440, DSM 11967, CCUG 68) Strain with reduced susceptibility to benzylpenicillin * Zone edges for S. pneumoniae on MH-F are often accompanied by α-haemolysis. Read inhibition of growth and not inhibition of haemolysis. Tilt the plate to easier differentiate between haemolysis and growth. There is usually growth in the whole area of α-haemolysis but on some MH-F media, there is additional α-haemolysis without growth. Disk diffusion methodology: Mueller-Hinton agar + 5% defibrinated horse blood and 0 mg/l β-nad, McFarland 0.5, 5% CO, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the front of the plate with the lid removed and with reflected light. Target 1 Range (µg) Target 1 Range Amoxicillin Ampicillin Azithromycin Benzylpenicillin unit Cefaclor Cefepime Cefotaxime Cefpodoxime Ceftaroline IP IP Ceftobiprole IP IP IP Ceftriaxone Cefuroxime Chloramphenicol Ciprofloxacin Clarithromycin Clindamycin Daptomycin Doripenem Doxycycline Ertapenem Erythromycin Imipenem Levofloxacin Linezolid Meropenem Minocycline Moxifloxacin Nitrofurantoin Norfloxacin Ofloxacin Oxacillin Rifampicin Teicoplanin Telithromycin Tetracycline Tigecycline Trimethoprim-sulfamethoxazole Vancomycin From International Standards Organisation, ISO : 006 (with updates as in the latest CLSI M100 document). Established and validated by EUCAST. 4 Clinical and Laboratory Standards Institute, M100-S5, 015, and validated by EUCAST. 5 For daptomycin determination, the medium must be supplemented with Ca + to a final concentration of 50 mg/l. 6 S. aureus ATCC 91 can be used for quality control of oxacillin 1 µg with target mm and range 19-5 mm. 7 For tigecycline broth microdilution determination, the medium must be prepared fresh on the day of use. 8 Trimethoprim:sulfamethoxazole in the ratio 1:19. values are expressed as the trimethoprim concentration. IP = In Preparation 9
11 Routine QC EUCAST QC Tables v. 5.0, valid from Haemophilus influenzae NCTC (CIP 54.94, CCUG 946) Disk diffusion methodology: Mueller-Hinton agar + 5% defibrinated horse blood and 0 mg/l β-nad, McFarland 0.5, 5% CO, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the front of the plate with the lid removed and with reflected light. Target Range (µg) Target Range Amoxicillin-clavulanic acid Note 1 Note Ampicillin Note 1 Note Benzylpenicillin Note 1 Note 1 1 unit Cefaclor Note 1 Note Cefepime Note 1 Note Cefixime Note 1 Note Cefotaxime Note 1 Note Cefpodoxime Note 1 Note Ceftaroline Note 1 Note Ceftibuten Note 1 Note Ceftriaxone Note 1 Note Cefuroxime Note 1 Note Chloramphenicol Note 1 Note Ciprofloxacin Note 1 Note Doripenem Note 1 Note Ertapenem Note 1 Note Erythromycin Note 1 Note Imipenem Note 1 Note Levofloxacin Note 1 Note Meropenem Note 1 Note Minocycline Note 1 Note Moxifloxacin Note 1 Note Nalidixic acid Note 1 Note Ofloxacin Note 1 Note Rifampicin Note 1 Note Telithromycin Note 1 Note Tetracycline Note 1 Note Trimethoprim-sulfamethoxazole Note 1 Note H. influenzae NCTC 8468 exhibits unusual growth characteristics and will be excluded from 016. Calculated by EUCAST. Established and validated by EUCAST. 10
12 Routine QC EUCAST QC Tables v. 5.0, valid from Haemophilus influenzae ATCC (NCTC 1975, CIP 10570, DSM 11970, CCUG 959) Disk diffusion methodology: Mueller-Hinton agar + 5% defibrinated horse blood and 0 mg/l β-nad, McFarland 0.5, 5% CO, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the front of the plate with the lid removed and with reflected light. Target 1 Range (µg) Target Range Amoxicillin-clavulanic acid Amoxicillin Ampicillin Ampicillin-sulbactam Azithromycin Benzylpenicillin unit Cefepime Cefixime Cefotaxime Cefpodoxime Ceftaroline IP IP Ceftibuten IP IP Ceftriaxone IP IP Cefuroxime Chloramphenicol Ciprofloxacin IP IP Clarithromycin Doripenem Doxycyline Ertapenem Erythromycin Imipenem Levofloxacin IP IP Meropenem Minocycline Moxifloxacin IP IP Nalidixic acid Ofloxacin IP IP Rifampicin Roxithromycin Telithromycin Tetracycline Trimethoprim-sulfamethoxazole Established and validated by EUCAST. For testing, the concentration of clavulanic acid is fixed at mg/l. 4 For testing, the concentration of sulbactam is fixed at 4 mg/l. 5 From Clinical and Laboratory Standards Institute, M100-S5, 015, and validated by EUCAST. 6 Trimethoprim:sulfamethoxazole in the ratio 1:19. values are expressed as the trimethoprim concentration. IP = In Preparation 11
13 Routine QC EUCAST QC Tables v. 5.0, valid from Campylobacter jejuni ATCC 560 (NCTC 1151, CIP 70, DSM 4688, CCUG 1184) Disk diffusion methodology: Mueller-Hinton agar + 5% defibrinated horse blood and 0 mg/l β-nad, McFarland 0.5, microaerobic environment, 41±1ºC, 4h. Read zone edges as the point showing no growth viewed from the front of the plate with the lid removed and with reflected light. The MH-F plates should be dried prior to inoculation to reduce swarming (at 0-5 C over night or at 5 C, with the lid removed, for 15 min). (µg) Target Range Target 1 Range Ciprofloxacin IP IP Erythromycin IP IP Tetracycline IP IP Established and validated by EUCAST. IP = In Preparation 1
14 Extended QC EUCAST QC Tables v. 5.0, valid from Quality control strains for detection of resistance mechanisms with disk diffusion on Mueller-Hinton agar Disk diffusion methodology: Mueller-Hinton agar, McFarland 0.5, air, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the back of the plate against a dark background illuminated with reflected light. Klebsiella pneumoniae ATCC (NCTC 168, CCUG 4541, CECT 7787) SHV-18 ESBL producer (µg) Target Range susceptibility 1 Aztreonam 0 R 9-17 Cefotaxime 5 I or R 1-18 Cefpodoxime 10 R 9-16 Ceftazidime 10 I or R 6-1 Ceftriaxone 0 I or R 16- Comments Staphylococcus aureus NCTC 149 Methicillin resistant (MRSA), meca positive (µg) Target Range susceptibility 1 Cefoxitin 0 R 14-0 Comments Enterococcus faecalis ATCC 5199 (NCTC 179,CIP , DSM 1956, CCUG 489) High-level gentamicin resistant (HLGR) (µg) Gentamicin 0 R 6 Teicoplanin 0 S 16-0 Vancomycin 5 R 6-1 Examine zone edge with transmitted light (plate held up to light). Inhibition zones with fuzzy zone edges are interpreted as resistant, even if the zone diameter is above the susceptible breakpoint. 1 Targets comply with EUCAST clinical breakpoints and are set to ensure that resistance mechanisms are correctly detected. Interpretation according to EUCAST clinical breakpoints: S=Susceptible, I=Intermediate, R=Resistant. From Clinical and Laboratory Standards Institute, M100-S5, 015, except ranges in bold/italics established by EUCAST. All ranges have been validated by EUCAST. Target Range susceptibility 1 Comments 1
15 Extended QC EUCAST QC Tables v. 5.0, valid from Quality control strains for detection of resistance mechanisms with disk diffusion on Mueller-Hinton fastidious (MH-F) agar Disk diffusion methodology: Mueller-Hinton agar + 5% defibrinated horse blood and 0 mg/l β-nad, McFarland 0.5, 5% CO, 5±1ºC, 18±h. Read zone edges as the point showing no growth viewed from the front of the plate with the lid removed and with reflected light. Haemophilus influenzae ATCC 4947 (NCTC 1699, CIP , DSM 9999, CCUG 614) Reduced susceptibility to β-lactam agents due to mutations in genes coding for PBP enzymes. (µg) Target Range susceptibility 1 Ampicillin R 6-1 Benzylpenicillin 1 unit R 6-9 Comments s are particularly affected by variation in medium, inoculum and incubation conditions. Inhibition zones with growth of small colonies within the zone are interpreted as 6 mm (no zone). 1 Targets comply with EUCAST clinical breakpoints and are set to ensure that resistance mechanisms are correctly detected. Interpretation according to EUCAST clinical breakpoints: S=Susceptible, I=Intermediate, R=Resistant. Established and validated by repeated testing by EUCAST. 14
Routine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationBritish Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method
More informationAMR Industry Alliance Antibiotic Discharge Targets
AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More informationBritish Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy Standing Committee on Susceptibility Testing Version 13.0, 10-06-2014 Content Page Additional information Changes in version 13 2 Suggestions for appropriate
More informationThere are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationBSAC standardized disc susceptibility testing method (version 8)
Journal of Antimicrobial Chemotherapy (2009) 64, 454 489 doi:10.1093/jac/dkp244 Advance Access publication 8 July 2009 BSAC standardized disc susceptibility testing method (version 8) J. M. Andrews* for
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationQuality assurance of antimicrobial susceptibility testing
Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationSMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...
SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* The next-generation MicroScan WalkAway System combines proven technology and reliability with enhanced ease-of-use features to streamline
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationBrief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents
Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationThis document is protected by international copyright laws.
Table 2C Table 2C. and s for Product Name: Infobase 2010 - Release Date: February 2010 60 Clinical and Laboratory Standards Institute. All rights reserved. Testing Conditions Medium: diffusion: MHA Broth
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationEducating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges
Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association
More informationPenicillins - EUCAST clinical MIC breakpoints (version 1.3)
EUCAST clinical MIC breakpoints - penicillins Penicillins - EUCAST clinical MIC breakpoints 2009-04-19 (version 1.3) Penicillins Click on antibiotic name to see wild type MIC distributions. Enterobacteriaceae
More informationInterpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes
Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Prof C. Wattal Hon. Sr. Consultant & Chairman Dept. of Clinical Microbiology Sir Ganga Ram Hospital New Delhi
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationEUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins
EUAST Expert Rules for 2018 Organisms Agents tested Agents affected Rule aureus Oxacillin efoxitin (disk diffusion), detection of meca or mec gene or of PBP2a All β-lactams except those specifically licensed
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationMain objectives of the EURL EQAS s
EQAS Enterococci, Staphylococci and E. coli EURL workshop, April, 11 Lourdes García Migura Main objectives of the EURL EQAS s To improve the comparability of antimicrobial susceptibility testing (AST)
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More informationPractical approach to Antimicrobial susceptibility testing (AST) and quality control
Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,
More informationVersion 7, January 2008
BSAC Methods for Antimicrobial Susceptibility Testing Version 7, January 2008 All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: jenny.andrews@swbh.nhs.uk 1 Contents Page Working Party members
More informationVersion 6, January 2007
BSAC Methods for Antimicrobial Susceptibility Testing Version 6, January 2007 All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: jenny.andrews@swbh.nhs.uk 1 Contents Page Working Party members
More informationVersion 13 January 2014
BSAC Methods for Antimicrobial Susceptibility Testing Version 13 January 2014 All enquiries to: Mandy Wootton Email: Mandy.Wootton@wales.nhs.uk Telephone: +44 (0) 2920 746581 Contents Page Working Party
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationVersion 9.1 March 2010
BSAC Methods for Antimicrobial Susceptibility Testing Version 9.1 March 2010 All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: jenny.andrews@swbh.nhs.uk Contents Page Working Party members
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationVersion 10.1 April 2011
BSAC Methods for Antimicrobial Susceptibility Testing Version 10.1 April 2011 All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: jenny.andrews1@nhs.net Contents Page Working Party members
More information1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
More informationEinheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?
Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis
More informationWhat is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown
What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints
More informationVersion 1.01 (01/10/2016)
CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationLab Exercise: Antibiotics- Evaluation using Kirby Bauer method.
Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationVersion 8 January 2009
BSAC Methods for Antimicrobial Susceptibility Testing All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: jenny.andrews@swbh.nhs.uk 2 Contents Page Working Party members 5 Abstract 6 Preface
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More information- the details, where possible, of the antibiotic products these companies supply or have supplied.
Under the Freedom of Information Act 2000 please could you provide me with a list of all companies currently supplying antibiotics - or that have supplied antibiotics in the last three years - to Royal
More informationEAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia
EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia Background The Expert Advisory Group on Antimicrobial Resistance of the NH&MRC provides advice to Australian governments and
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationEUCAST expert rules in antimicrobial susceptibility testing
REVIEW BACTERIOLOGY EUCAST expert rules in antimicrobial susceptibility testing R. Leclercq 1,2, R. Cantón 2,3,4, D. F. J. Brown 4, C. G. Giske 2,4,5, P. Heisig 2,6, A. P. MacGowan 4,7, J. W. Mouton 4,8,
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More informationTaiwan Surveillance of Antimicrobial Resistance (TSAR)
Taiwan Surveillance of Antimicrobial Resistance (TSAR) 2009 MIRL Symposium July 17, 2009 Tsai-Ling Yang Lauderdale ( ) Microbial Infections Reference Laboratory (MIRL) Division of Infectious Diseases,
More informationRecommendations to take it forward!
Capacity Building and Strengthening of Hospital Infection Control to detect and prevent antimicrobial resistance in India AIIMS-ICMR-CDC EQAS Recommendations to take it forward! Top regional diagnostic
More informationAPPENDIX III - DOUBLE DISK TEST FOR ESBL
Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #116 (NQF 0058): Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationQUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)
Pseudomonas aeruginosa (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Description: Greenish gray colonies with some beta-hemolysis around each colony on blood agar (BAP),
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More information1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS
PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...
More informationIntroduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.
Secondary Care Data Validation: What do commissioners need to know? Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2014 Introduction Antimicrobial
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationNon-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,
Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland, 2008-2016 Alicia Russell Federation of Infection Societies conference 14 th November 2018 alisia_russell BSAC
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(11):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 11 (2017) pp. 2293-2299 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.611.272
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationAntimicrobial Resistance Strains
Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationEvaluation of the BIOGRAM Antimicrobial Susceptibility Test System
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility
More informationEARS-Net Belgium Data call for 2016: Instructions for participating laboratories, including data definition. (version 4, 20/3/2017)
EARS-Net Belgium Data call for 2016: Instructions for participating laboratories, including data definition. (version 4, 20/3/2017) Questions on this document can be directed towards: Karl Mertens Scientific
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationCAP Laboratory Improvement Programs. Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods
CAP Laboratory Improvement Programs Performance Accuracy of Antibacterial and Antifungal usceptibility Test Methods Report From the College of American Pathologists Microbiology urveys Program (001 003)
More informationANTIMICROBIAL RESISTANCE SURVEILLANCE FROM SENTINEL PUBLIC HOSPITALS, SOUTH AFRICA, 2014
ANTIMICROBIAL RESISTANCE SURVEILLANCE FROM SENTINEL PUBLIC HOSPITALS, SOUTH AFRICA, 2014 Olga Perovic, 1,2 Verushka Chetty 1 & Samantha Iyaloo 1 1 National Institute for Communicable Diseases, NHLS 2 Department
More information